One-pot friedlnder quinoline synthesis: Scope and limitations

Synthesis

Volumn , Issue 10, 2010, Pages 1678-1686

  Li, An Hu ^a   Beard, David J ^a   Coate, Heather ^a   Honda, Ayako ^a   Kadalbajoo, Mridula ^a   Kleinberg, Andrew ^a   Laufer, Radoslaw ^a   Mulvihill, Kristen M ^a   Nigro, Anthony ^a   Rastogi, Pawan ^a   Sherman, Dan ^a   Siu, Kam W ^a   Steinig, Arno G ^a   Wang, Ti ^a   Werner, Doug ^a   Crew, Andrew P ^a   Mulvihill, Mark J ^a  

^a OSI PHARMACEUTICALS INC   (United States)

Author keywords

Aldehydes; Condensation; Heterocycles; Ketones; Quinolines

Indexed keywords

AMINO-COMPOUNDS; CATALYTIC AMOUNTS; HETEROCYCLES; IN-SITU; ONE POT;

ALDEHYDES; CONDENSATION; HYDROCHLORIC ACID; SYNTHESIS (CHEMICAL);

KETONES;

1,2,3,4 TETRAHYDROACRIDINE; 1,3 AMINOARYLCARBALDEHYDE DERIVATIVE; 1,3 NITROARYLCARBALDEHYDE DERIVATIVE; 11H INDENO[1,2 B]QUINOLINE; 2 (1 METHYL 1H PYRROL 2 YL)QUINOLINE; 2 (1,3 BENZODIOXOL 5 YL)QUINOLINE; 2 (2 THIENYL)QUINOLINE; 2 (DIMETHOXYMETHYL)QUINOLINE; 2 [2 PHENYLVINYL]QUINOLINE; 2 CYCLOPROPYLQUINOLINE; 2 PHENYLBENZO[H]QUINOLINE; 2 PHENYLQUINOLINE; 2 PHENYLQUINOLINE 7 CARBOXYLIC ACID; 2 PYRIDIN 2YLQUINOLINE; 2 TERT BUTYLQUINOLINE; 3 ETHYL 2 PROPYLQUINOLINE; 3 METHOXY 2 PHENYLQUINOLINE; 3 METHYL 2 PHENYLQUINOLINE; 3 PHENYLQUINOLINE; 3 TERT BUTYL 1 METHYL 5 PHENYL 1H PYRAZOLO[4,3 B]PYRIDINE; 6 PHENYL[1,3]DIOXOLO[4,5 G]QUINOLINE; 7 BROMO 2 PHENYLQUINOLINE; 7 CHLORO 2 (2 CHLOROPHENYL)QUINOLINE; 7 CHLORO 2 (2 FLUOROPHENYL)QUINOLINE; ALDEHYDE DERIVATIVE; N,N DIMETHYL 2 PHENYLQUINOLIN 7 AMINE; QUINALDINE; QUINOLINE 2 CARBOXYLIC ACID; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CATALYSIS; CHEMICAL MODIFICATION; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; ONE POT SYNTHESIS; POLYMERIZATION; REACTION ANALYSIS;

EID: 77952059997     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0029-1218701     Document Type: Article

References (30)

1. For recent reviews, see:, Stocks P A., Raynes K J., Ward S A., In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Infectious Disease) Rosenthal P J. Humana Totawa / NJ 2001 Chap. 13 235
2. Waters N C., Dow G S., Kozar M P., Expert Opin. Ther. Pat. 2004 14 1125
3. Fitch C D., Life Sci. 2004 74 1957
4. Olliaro P L., Taylor W R. J., J. Exp. Biol. 2003 206 3753
5. Michael J P., Nat. Prod. Rep. 2004 21 650
6. Tsou H.-R, Overbeek-Klumpers E G., Hallett W A., Reich M F., Floyd M B., Johnson B D., Michalak R S., Nilakantan R, Discafani C, Golas J, Rabindran S K., Shen R, Shi X, Wang Y.-F, Upeslacis J, Wissner A, J.Med. Chem. 2005 48 1107
7. Boschelli D H., Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2002 2 1051
8. Kubo K, Ohyama S.-i, Shimizu T, Takami A, Murooka H, Nishitoba T, Kato S, Yagi M, Kobayashi Y, Iinuma N, Isoe T, Nakamura K, Iijima H, Osawa T, Izawa T, Bioorg. Med. Chem. 2003 11 5117
9. Golas J M., Arndt K, Etienne C, Lucas J, Nardin D, Gibbons J, Frost P, Ye F, Boschelli D H., Boschelli F, Cancer Res. 2003 63 375
10. Wu J, Li W, Craddock B P., Foreman K W., Mulvihill M J., Ji Q.-s, Miller W T., Hubbard S R., EMBO J. 2008 27 1985
11. Mulvihill M J., Ji Q.-S, Coate H R., Cooke A, Dong H, Feng L, Foreman K, Rosenfeld-Franklin M, Honda A, Mak G, Mulvihill K M., Nigro A I., OConnor M, Pirrit C, Steinig A G., Siu K, Stolz K M., Sun Y, Tavares P A. R., Yao Y, Gibson N W., Bioorg. Med. Chem. 2008 16 1359
12. Ji Q.-s, Mulvihill M J., Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, OConnor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold L D., Gibson N W., Pachter J A., Mol. Cancer Ther. 2007 6 2158
13. Mulvihill M J., Cooke A, Rosenfeld-Franklin M, Buck E, Foreman K, Landfair D, OConnor M, Pirritt C, Sun Y, Yao Y, Arnold L D., Gibson N W., Ji Q.-s, Future Med. Chem. 2009 1 1153
14. For a review, see:, Cheng C.-C, Yan S.-J, Org. React. (N. Y.) 1982 28 37
15. Muchowski J M., Maddox M L., Can. J. Chem. 2004 82 461
16. McNaughton B R., Miller B L., Org. Lett. 2003 5 4257
17. Eckert H, Angew. Chem. 1981 93 216
18. Motokura K, Mizugaki T, Ebitani K, Kaneda K, Tetrahedron Lett. 2004 45 6029
19. Cho C S., Kim B T., Choi H.-J, Kim T.-J, Shim S C., Tetrahedron 2003 59 7997
20. Martinez R, Ramon D J., Yus M, Eur. J. Org. Chem. 2007 1599
21. Cho C S., Ren W X., Shim S C., Tetrahedron Lett. 2006 47 6781
22. Cho C S., Ren W X., Shim S C., Bull. Korean Chem. Soc. 2005 26 1286
23. Li A.-H, Ahmed E, Chen X, Cox M, Crew A P., Dong H.-Q, Jin M, Ma L, Panicker B, Siu K W., Steinig A G., Stolz K M., Tavares P A. R., Volk B, Weng Q, Werner D, Mulvihill M J., Org. Biomol. Chem. 2007 5 61
24. Arnold L D., Cesario C, Coate H, Crew A P., Dong H, Foreman K, Honda A, Laufer R, Li A.-H, Mulvihill K M., Mulvihill M J., Nigro A, Panicker B, Steinig A G., Sun Y, Weng Q, Werner D S., Wyle M J., Zhang T, WO 2005097800, 2005; Chem. Abstr. 2005, 142, 405928
25. 2N group is -0.205, suggesting that it has an electron-donating effect. See:, Hammett L P., J. Am. Chem. Soc. 1937 59 96
26. Longer condensation times have also been reported for the reaction of the intermediate 1-aminonaphthalene-2-carboxaldehyde with 1,3-diacetylbenzene (31 h) and 2,6-diacetylpyridine (17 h) under essentially the same reaction conditions (KOH in refluxing EtOH); see:, Riesgo E C., Jin X, Thummel R P., J. Org. Chem. 1996 61 3017
27. Fournet A, Vagneur B, Richomme P, Bruneton J, Can. J. Chem. 1989 67 2116
28. Fournet A, Hocquemiller R, Roblot F, Cavé A, Richomme P, Bruneton J, J. Nat. Prod. 1993 56 1547
29. Caron S, Desfossés S, Dionne R, Théberge N, Burnell R H., J. Nat. Prod. 1993 56 138
30. The same results were obtained in the 1,8-naphthyridine system when NaOH was used as the base. See:, Dormer P G., Eng K K., Farr R N., Humphrey G R., McWilliams G C., Reider P J., Sager J W., Volante R P., J. Org. Chem. 2003 68 467